Stocks to watch

NAB - NATIONAL AUSTRALIA BANK - down 68 cents, or 2.3 per cent, to $29.02

National Australia Bank will cop a $1.18 billion hit in its full-year results, including an extra $832 million to repay customers wronged by the fees-for-no-service advice scandal and dodgy insurance.

NAB's royal commission remediation bill now stands at $2.09 billion after it was dragged over the coals at the damaging Hayne inquiry.

MYX - MAYNE PHARMA - up 10 cents, or 18.9 per cent, to 63 cents

The pharmaceutical company has inked an exclusive long-term deal to sell a new contraceptive drug in the United States, with a 20-year supply and licence agreement with Belgium-based Mithra Pharmaceuticals to commercialise a "next generation" contraceptive pill.

Estelle is a fifth-generation oral contraceptive that Mithra believes will have less effect on liver metabolism and lipids than

ISX - ISIGNTHIS - flat at $1.07

Shares in iSignthis were suspended by the ASX following consultation by the Australian Securities and Investments Commission and "having regard to the recent volatility in its share price".

The shares would remain suspended "pending the outcome of enquiries to be made by ASIC and ASX into a number of issues concerning ASX," the exchange said, without elaboration.

Austrlaian Associated PressBack to Breaking News

  • Print this page
  • Copy Link